Report of six XXXX -associated @entity12692 cases.

@entity1 @entity644 @entity8 @entity455 @entity9107 @entity4 @entity229 @entity12692 @entity1295 @entity1050 @entity786 @entity177 @entity12321 @entity1891 @entity1986 @entity631 @entity221
UNASSIGNED: @entity12692 ( @entity12692 ) is an uncommon, benign, non-neoplastic, lymphoproliferative disease of uncertain etiology. Here, we report 6 cases of @entity8 in China. All @entity1 exhibited @entity12321 ( @entity1050 ) with involvement of the mediastinum, neck, bilateral axillary, and bilateral inguinal regions. Clinical manifestations included @entity221 , @entity1295 , @entity4 , and swollen lymph nodes. Laboratory examinations of all 6 @entity1 found @entity644 or @entity177 . Two of the @entity1 were diagnosed with @entity455 , and 4 @entity1 were diagnosed with plasma cell type @entity12692 . The case 1 and case 4 @entity1 had mesangial proliferative @entity631 , case 3 had type I membranoproliferative @entity631 , case 2 and case 5 had @entity1986 , and case 6 had @entity8 . Three @entity1 were treated with @entity229 plus @entity786 , 1 @entity1 received @entity9107 therapy ( @entity786 , @entity1891 and @entity229 ), and 2 @entity1 received @entity9107 therapy supplemented by small doses of radiation therapy delivered to local lymph nodes. In all cases, the clinical manifestations of @entity1050 , including @entity221 , @entity1295 , @entity4 , swollen lymph nodes, and @entity644 , were alleviated or abolished by treatment. One @entity1 responded to treatment with @entity1050 , and another 4 @entity1 survived. However, 1 @entity1 died due to @entity177 . In conclusion, common diagnosis and treatment techniques are suitable for @entity8 . However, treatment efficacy might be difficult to predict, and some cases may have poor prognosis with this treatment strategy. Therefore, additional studies investigating @entity8 and treatment outcomes in larger @entity1 populations are needed.
